BDBM50292935 CHEMBL521649::N-butyl-2-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-2-phenylacetamide

SMILES CCCCNC(=O)C(N1CCc2cc(OC)c(OC)cc2C1Cc1ccc(OC)c(OC)c1)c1ccccc1

InChI Key InChIKey=IHCFTGHARRXKNR-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50292935   

TargetOrexin/Hypocretin receptor type 1(Human)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292935(N-butyl-2-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3...)
Affinity DataIC50: 75nMAssay Description:Inhibition of OX1 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2010
Entry Details Article
PubMed
TargetOrexin receptor type 2(Human)
Actelion Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50292935(N-butyl-2-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3...)
Affinity DataIC50: 1.81E+3nMAssay Description:Inhibition of OX2 receptorMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/25/2010
Entry Details Article
PubMed